Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
SPG5 and multiple sclerosis: clinical and genetic overlap?
Specificities of children with multiple sclerosis and neuromyelitis optica.
Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic Review.
CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.
Lesional accumulation of CD8(+) cells in sciatic nerves of experimental autoimmune neuritis rats.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
Acute transverse myelitis in a child with lyme disease and a review of literature.
Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis.
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation.
Width of 3. Ventricle: reference values and clinical relevance in a cohort of patients with relapsing remitting multiple sclerosis.
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
Measurement and maintenance of reserve in multiple sclerosis.
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
Magnetic susceptibility contrast variations in multiple sclerosis lesions.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
Trichloropropane and dichlorohydrin associated with painful peripheral neurotoxicity.
Systematic Review of the Epidemiology of Urinary Incontinence and Detrusor Overactivity among Patients with Neurogenic Overactive Bladder.
Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis.
Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome.
Pages
« first
‹ previous
…
617
618
619
620
621
622
623
624
625
…
next ›
last »